These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16135370)

  • 1. An analytical solution for percutaneous drug absorption: application and removal of the vehicle.
    Simon L; Loney NW
    Math Biosci; 2005 Oct; 197(2):119-39. PubMed ID: 16135370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated applications of a transdermal patch: analytical solution and optimal control of the delivery rate.
    Simon L
    Math Biosci; 2007 Oct; 209(2):593-607. PubMed ID: 17490691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
    Simon L; Ospina J
    Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interfacial kinetics effects on transdermal drug delivery: a computer modeling.
    Xing MM; Pan N; Zhong W; Hui X; Maibach HI
    Skin Res Technol; 2008 May; 14(2):165-72. PubMed ID: 18412558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finite dose percutaneous drug absorption: theory and its application to in vitro timolol permeation.
    Kubota K; Yamada T
    J Pharm Sci; 1990 Nov; 79(11):1015-9. PubMed ID: 2292763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A random walk method for percutaneous drug absorption pharmacokinetics: application to repeated administration of a therapeutic timolol patch.
    Kubota K; Koyama E; Yasuda K
    J Pharm Sci; 1991 Aug; 80(8):752-6. PubMed ID: 1791535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-dimensional mathematical model of percutaneous drug absorption.
    George K; Kubota K; Twizell EH
    Biomed Eng Online; 2004 Jun; 3(1):18. PubMed ID: 15202943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).
    Ohno Y; Iga T; Yamada Y; Nagahara M; Araie M; Takayanagi R
    Curr Eye Res; 2005 Apr; 30(4):319-28. PubMed ID: 16020262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the iontophoretic and passive transdermal delivery of timolol maleate across human cadaver skin.
    Soni S; Dixit VK
    Pharmazie; 1994 Jan; 49(1):73-4. PubMed ID: 8140139
    [No Abstract]   [Full Text] [Related]  

  • 11. A two-phase two-layer model for transdermal drug delivery and percutaneous absorption.
    Pontrelli G; de Monte F
    Math Biosci; 2014 Nov; 257():96-103. PubMed ID: 24835077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of timolol by electroporation through human skin.
    Denet AR; Préat V
    J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diffusion-diffusion model for percutaneous drug absorption.
    Kubota K; Ishizaki T
    J Pharmacokinet Biopharm; 1986 Aug; 14(4):409-39. PubMed ID: 3772740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of diffusion with partitioning in stratum corneum using a finite element model.
    Barbero AM; Frasch HF
    Ann Biomed Eng; 2005 Sep; 33(9):1281-92. PubMed ID: 16133933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finite element modeling of coupled diffusion with partitioning in transdermal drug delivery.
    Rim JE; Pinsky PM; van Osdol WW
    Ann Biomed Eng; 2005 Oct; 33(10):1422-38. PubMed ID: 16240090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental verification of the mechanistic model for transdermal transport including iontophoresis.
    Hirvonen J; Murtomäki L; Kontturi K
    J Control Release; 1998 Dec; 56(1-3):169-74. PubMed ID: 9801440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iontophoretic enhancement of timolol across human dermatomed skin in vitro.
    Fatouros DG; Bouwstra JA
    J Drug Target; 2004 Jan; 12(1):19-24. PubMed ID: 15203908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
    Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
    Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels.
    Wei G; Ding PT; Zheng JM; Lu WY
    Biomed Chromatogr; 2006 Jan; 20(1):67-71. PubMed ID: 15954162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial distribution of cutaneous microvasculature and local drug clearance after drug application on the skin.
    Cevc G; Vierl U
    J Control Release; 2007 Mar; 118(1):18-26. PubMed ID: 17254662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.